Azithromycin antimicrobial resistance and genital Chlamydia trachomatis infection: duration of therapy may be the key to improving efficacy

Sex Transm Infect. 2012 Apr;88(3):154-6. doi: 10.1136/sextrans-2011-050385.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Anti-Bacterial Agents / administration & dosage*
  • Anti-Bacterial Agents / pharmacology
  • Azithromycin / administration & dosage*
  • Azithromycin / pharmacology
  • Chlamydia trachomatis / drug effects*
  • Chlamydia trachomatis / isolation & purification
  • Drug Resistance, Bacterial*
  • Drug Therapy / methods*
  • Female
  • Humans
  • Lymphogranuloma Venereum / drug therapy*
  • Lymphogranuloma Venereum / microbiology*
  • Male
  • Time Factors
  • Treatment Outcome

Substances

  • Anti-Bacterial Agents
  • Azithromycin